-
1 Comment
Meilleure Health International Industry Group Limited is currently in a long term downtrend where the price is trading 10.5% below its 200 day moving average.
From a valuation standpoint, the stock is 235.0% more expensive than other stocks from the Industrials sector with a price to sales ratio of 7.5.
Meilleure Health International Industry Group Limited's total revenue rose by 4.5% to $132M since the same quarter in the previous year.
Its net income has increased by 166.7% to $41M since the same quarter in the previous year.
Finally, its free cash flow grew by 621.9% to $50M since the same quarter in the previous year.
Based on the above factors, Meilleure Health International Industry Group Limited gets an overall score of 3/5.
| CurrencyCode | HKD |
|---|---|
| Industry | Conglomerates |
| Exchange | HK |
| Sector | Industrials |
| ISIN | BMG5975D1048 |
| Market Cap | 1B |
|---|---|
| PE Ratio | 29.5 |
| Target Price | 2.62 |
| Dividend Yield | 1.4% |
| Beta | 0.12 |
Meilleure Health International Industry Group Limited, an investment holding company, engages in trading of construction and photovoltaic components and materials business in Hong Kong, the People's Republic China, Europe, and internationally. It operates through four segments: Healthcare-Related Business, Trading Business, Property-Related Business, and Equity Investment Business. The company provides health management and aesthetic medical services, as well as sells healthcare-related and cannabidiol downstream products; develops and sells residential properties; and engages in the trading of construction materials and renewable energy products; provision of renewable energy product procurement services; and sales agency services for healthcare-related products. It is also involved in property investment and leasing activities; and provision of management, and real estate agency services. The company was founded in 1891 and is headquartered in Admiralty, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2327.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
